Objective Data on serial liver biochemistries of patients infected by different human
coronaviruses (HCoVs) are lacking. The impact of liver injury on adverse clinical outcomes …

Patients with tuberculosis (TB) disease treated with multi‐drug regimens are at risk of
developing drug induced liver injury (DILI), and DILI risk might be even higher in patients …

Background There is a substantial overlap in the epidemiology of chronic hepatitis B (HBV),
hepatitis C (HCV) and tuberculosis (TB) due to overlapping risk factors. Testing for viral …

Background and Aims We compared risk of acute liver injury and mortality in patients with
COVID‐19 and current, past, and no HBV infection. Approach and Results This was a …

Background The case-fatality ratios (CFR) of coronavirus disease 2019 (COVID-19) and
severe acute respiratory syndrome (SARS) appeared to differ substantially. We aimed to …

Background Severe acute respiratory syndrome (SARS) and coronavirus disease 2019
(COVID-19) are closely related. The effect of AKI on the clinical outcomes of these two …

Background Liver injury in patients with coronavirus disease 2019 (COVID-19) is common
and prognostic. Direct viral tropism of severe acute respiratory syndrome coronavirus 2 …

Tuberculosis (TB) and chronic hepatitis B virus (CHB) infection can be prevented with
treatment and vaccination, respectively. We reviewed epidemiology and guidelines for TB …

• Adverse events and treatment interruption are more common in these special populations;
close monitoring and additional support is often needed.• Given alterations in TB-drug …

Objective: To evaluate patterns of HBV and LTBI testing and prevalence of HBV-LTBI
coinfection in the United States. Design: Retrospective cohort study. Setting: Quest …